Greece reduces VAT on pharmaceutical rebates

International Tax Review is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greece reduces VAT on pharmaceutical rebates

Sponsored by

eygreece.png
Pharmaceuticals - Cover

After a long-standing debate, Greece's tax authority has reduced the VAT threshold for pharmaceutical rebates. EY Greece's Nikoletta Merkouri discusses the impact for pharmaceutical companies.

Greece’s Tax Administration acknowledged in Decision A. 1035 on February 5 2019 a reduction in the taxable amount for value added tax (VAT) for rebates granted by pharmaceutical companies to social security organisations and hospitals (Article 35, Paragraph 3 of Law 3918/2011).  

The issue has been a long-standing debate between pharmaceutical businesses and the Greek State. Under the former system, VAT corresponding to rebates was a cost suffered by the pharmaceutical businesses.

Greece’s Supreme Administrative Court has already issued decisions that determine that rebates constitute an obligatory limitation of monetary claims by pharmaceutical companies against the social security organisations, when supplying medicinal products to the latter for the benefit of the insured persons. The cost of these supplies is covered totally or partially by the social security organisation.

In simple terms, this is a reduction/discount to the original amount for the supply of the medicinal products. This is seen in Decisions 3447/2015, 3448/2015, 3449/2015 and 3450/2015, 2049/2017 and 1282/2017 of Greece’s Supreme Administrative Court.

Greece’s Tax Administration has previously accepted in Decision 1115/2016 a reduction in the taxable amount for VAT in similar situations where there is a claw-back granted by pharmaceutical companies to social security organisations (Article 11 of Law 4052/2012) and hospitals.

This is also the case of rebates granted by private pharmacies (Article 34 of Law 3918/2011) and private health services providers (Article 100 of Law 4172/2013) to social security organisations. As a result, rebates and claw-backs are now treated in a uniform manner from a VAT point of view, on account of application of the principle of equal treatment.

Consequently, the Greek Tax Administration is aligned with the judgment of the Court of Justice of the European Union (CJEU) in C-462/16 (Boehringer Ingelheim Pharma GmbH. & Co. KG), as well as in C-317/94 (Elida Gibbs), with respect to the correct interpretation and application of Article 90, Paragraph 1 of Directive 2006/112/EC (VAT Directive).

This provision embodies one of the fundamental principles of the VAT Directive, according to which the taxable amount is the consideration received, and the corollary of which is that the tax authorities may not collect an amount of VAT exceeding the tax that the taxable person received.

Finally, the CJEU has upheld that one of the principles on which the VAT system is based is neutrality. In that sense, each country with similar goods should bear the same tax burden, whatever the length of the production and distribution chain.  

The impact of this development is that pharmaceutical companies will now be able to enhance their cash position by the amount of VAT corresponding to the rebates granted to social security organisations and hospitals.

N.Merkouri - Small

Nikoletta Merkouri

This article was written by Nikoletta Merkouri of EY Greece.

Email: nikoleta.merkouri@gr.ey.com

more across site & shared bottom lb ros

More from across our site

Thanks to operational slickness and sheer force of will, A&M Tax will continue hoovering up talent across the globe
Setu Kamal became the first practising barrister to be added to the UK’s tax avoidance promoter list; in other news, UHY expanded its network in Canada
US President Donald Trump’s tariffs may get thrown out by courts in the future and taxpayers should already be planning for that possibility, BDO’s Dustin Stamper tells ITR
Awards
ITR is delighted to reveal the first shortlisted nominees for the Middle East Tax Awards
The firm has appointed Deloitte’s former tax leader for Thailand to lead the new operation, which builds on considerable Asian investment in recent months
The Donald Trump administration could use legislation from 1930 if the Supreme Court blocks its tariffs; in other news, China has updated its VAT refund procedures
Braun gives ITR an exclusive insight into WTS Digital’s UK launch of its AI product, which can free up more than 1,500 hours per month by reducing routine tasks
Long tells ITR about her varied role, why curiosity is a key characteristic for the tax professional, and what she’d be doing if she wasn’t working in tax
The choice facing governments is not whether to adopt AI in taxation, but how to do so in a way that upholds the principles of tax fairness, writes Neil Kelley
As ITR’s client data reveals discontent with German tax advisers’ cost management, Grant Thornton’s local TP head insists it’s a two-way street
Gift this article